title: The impact of inpatient rivaroxaban versus warfarin on hospital-based outcomes when used for stroke prevention in patients with anticoagulant naïve, new-onset nonvalvular atrial fibrillation.
authors.affiliation: Pharmacy Services, Hartford Hospital, 80 Seymour St., Hartford, CT 06102, USA. Electronic address: Caitlyn.hurley@hhchealth.org.
authors.forename: Caitlyn
authors.initials: C
authors.lastname: Hurley
authors.affiliation: University of Connecticut School of Pharmacy, Department of Pharmacy Practice, 69 N. Eagleville Rd. Unit 3092, Storrs, CT 06269, USA. Electronic address: Shurui.dai@uconn.edu.
authors.forename: Shurui
authors.initials: S
authors.lastname: Dai
authors.affiliation: University of Connecticut School of Pharmacy, Department of Pharmacy Practice, 69 N. Eagleville Rd. Unit 3092, Storrs, CT 06269, USA. Electronic address: Diana.sobieraj@uconn.edu.
authors.forename: Diana M
authors.initials: DM
authors.lastname: Sobieraj
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D065427:Factor Xa Inhibitors / Q000627:therapeutic use*; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D012189:Retrospective Studies; D000069552:Rivaroxaban / Q000627:therapeutic use*; D020521:Stroke / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D014859:Warfarin; D000069552:Rivaroxaban
keywords: Anticoagulant; Atrial fibrillation; Stroke prevention